The seventh batch of national organizational drug collection and mining bidding drug list and price announcement involved 31 treatment categories

On the 12th, under the organizational and guidance of relevant departments such as the State Medical Insurance Bureau, the seventh batch of centralized procurement of drugs for drugs in Nanjing was opened in Nanjing.

This episode of drugs involves 31 treatment categories, including common diseases such as hypertension, diabetes, anti -infection, digestive tract diseases, and major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer. Get strong. Taking the first -line liver cancer -targeted Yaolunbutoni capsule as an example, each drop from an average of 108 yuan to an average of 18 yuan, and a healing cycle can save 8,100 yuan. For the first time in the field of lowering blood pressure, it was included in the slow -controlled release agent. The price of nifeding horizontal control was 58%reduced, and the price of Matolol's slow -release tablet was 53%. The burden on the medication of patients with hypertension was significantly reduced. Anti -virus drug Osdivir's per tablet decreased from 4.5 yuan to 1 yuan. In addition, Pfizer's Donalin, Japan's Anstelai Mikafen Pure, Emmiro of Spain, Emmoro, and Bryko Xinyi, Italy, 4 original research medicines In the election, the average price was reduced by 67%. At this point, the country has organized seven batches of centralized bands to purchase, and a total of 294 drugs have been successfully purchased.

(CCTV reporter Zhang Ping)

Source: CCTV News

- END -